Specific gut bacteria increase risk of severe malaria

Researchers have identified multiple species of bacteria that, when present in the gut, are linked to an increased risk of developing severe malaria in humans and mice. Their findings could lead to the development of new approaches targeting gut bacteria to prevent severe malaria and associated deaths.

IU School of Medicine expands point-of-care ultrasound training

Indiana University School of Medicine is expanding its training program for point-of-care ultrasound (POCUS) by investing in portable ultrasound systems for all students, residents, and fellows across seven specialties to use in curricula and patient care at the academic health center in Indianapolis.

Internationally recognized computational researcher Spyridon Bakas, PhD, to serve as inaugural director of Division of Computational Pathology

Indiana University School of Medicine Department of Pathology is launching a new Division of Computational Pathology and a Research Center for Federated Learning in Precision Medicine.

Study: health equity an important aspect of improving quality of care provided to children in emergency departments

A new multi-site study led by Indiana University School of Medicine found increasing pediatric readiness in emergency departments reduces, but does not eliminate, racial and ethnic disparities in children and adolescents with acute medical emergencies.

John C. Kincaid, MD, Receives AANEM’s Prestigious 2023 Lifetime Achievement Award

The American Association of Neuromuscular &
Electrodiagnostic Medicine (AANEM) proudly announces Dr. John C. Kincaid as the 2023
Lifetime Achievement Award recipient for his lifelong dedication to research, patient care,
advocacy, and education.

Dr. Liana Apostolova is available to comment on new results of a phase III clinical trial of Donanemab, an Alzheimer’s disease medication for patients with early symptoms of the disease.

Liana Apostolova, MD is the associate dean of Alzheimer’s disease research at Indiana University School of Medicine. Dr. Apostolova and others presented results of the phase 3 clinical trial of Donanemab at the Alzheimer’s Association International Conference. The study, also published…

IU-developed statewide initiative shows primary care clinicians can diagnose autism in young children with high accuracy

A new study led by Indiana University School of Medicine researchers shows primary care clinicians who receive specialized training can make accurate autism diagnoses for over 80 percent of young children referred with developmental delays, providing compelling evidence that community-based models of autism evaluation are a potential solution for improving access to this needed service.

Deaths by suicide increase significantly during the week of a full moon

For centuries, people have suspected a full moon in the sky to cause mysterious changes in people. Now, psychiatrists at Indiana University School of Medicine have found deaths by suicide increase during the full moon.

IU researchers receive $8.6M NIH grant renewal to study alcohol use, binge drinking

A multi-disciplinary team of Indiana University researchers is focusing their efforts on a growing public health concern: binge and “high-intensity” drinking—extreme drinking behaviors that are increasingly prevalent among college-age adults.

IU neuroscientists lead new study laying groundwork for Alzheimer’s disease precision medicine

A 5-year, $41 million study will help researchers better understand the biological pathways underlying Alzheimer’s disease and ultimately create more personalized patient care through the development of a blood test for multiple pathways implicated in the disease – enabling earlier and less-invasive diagnosis.